OPC Pharmaceutical JSC (OPC) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

DHG Pharmaceutical JSC

Mediplantex National Pharmaceutical JSC

OPC Pharmaceutical JSC

Domesco Medical Import-Export JSC

Binh Dinh Pharmaceutical & Medical Equipment JSC

F.I.T. Investment JSC

Ben Tre Pharmaceutical JSC

Imexpharm Corp.

Ha Tay Pharmaceutical JSC

Cuu Long Pharmaceutical JSC

Mekophar Chemical Pharmaceutical JSC

Why is OPC Pharmaceutical JSC ?

High Management Efficiency with a high ROE of 15.33%

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 53.82

The company has declared Negative results for the last 9 consecutive quarters

INTEREST COVERAGE RATIO(Q) Lowest at 1,119.58
INTEREST(Q) Highest at VND 4,004.61 MM

With ROE of 10.56%, it has a fair valuation with a 1.69 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -4.49%, its profits have fallen by -2.5%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -4.49% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to OPC Pharmaceutical JSC should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is OPC Pharmaceutical JSC for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

OPC Pharmaceutical JSC

-4.49%

-0.33

26.22%

Vietnam VN Ho Chi Minh Index

43.59%

1.93

22.62%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

3.13%

EBIT Growth (5y)

-0.03%

EBIT to Interest (avg)

53.82

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.31

Sales to Capital Employed (avg)

1.25

Tax Ratio

19.56%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

28.43%

ROE (avg)

15.33%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.69

EV to EBIT

9.71

EV to EBITDA

8.21

EV to Capital Employed

2.02

EV to Sales

1.19

PEG Ratio

Dividend Yield

ROCE (Latest)

20.79%

ROE (Latest)

10.56%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -6.77% (YoY

CASH AND EQV(HY)

Highest at VND 589,323.07 MM

DEBT-EQUITY RATIO (HY)

Lowest at -36.16 %

INVENTORY TURNOVER RATIO(HY)

Highest at 1.6 times

OPERATING PROFIT(Q)

Highest at VND 44,834.69 MM

PRE-TAX PROFIT(Q)

Highest at VND 41,337.16 MM

-13What is not working for the Company

INTEREST COVERAGE RATIO(Q)

Lowest at 1,119.58

INTEREST(Q)

Highest at VND 4,004.61 MM

Here's what is working for OPC Pharmaceutical JSC

Operating Profit

Highest at VND 44,834.69 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (VND MM)

Pre-Tax Profit

Highest at VND 41,337.16 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (VND MM)

Cash and Eqv

Highest at VND 589,323.07 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -36.16 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 1.6 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -6.77% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for OPC Pharmaceutical JSC

Interest

At VND 4,004.61 MM has Grown at inf%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

Interest Coverage Ratio

Lowest at 1,119.58

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest

Highest at VND 4,004.61 MM

in the last five periods and Increased by inf% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (VND MM)

Non Operating Income

Highest at VND 0.14 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income